Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia

Biological Psychiatry

Volumn 52, Issue 7, 2002, Pages 729-739

  Leumann, Lorenz ^a   Feldon, Joram ^b   Vollenweider, Franz X ^c,d   Ludewig, Katja ^e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Research Department   (Switzerland)

^e Aargau Canton AG   (Switzerland)

Author keywords

Latent inhibition; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Typical and atypical antipsychotics

Indexed keywords

CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PENFLURIDOL; QUETIAPINE; RISPERIDONE; ZUCLOPENTHIXOL DECANOATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; ELECTROMYOGRAPHY; FEMALE; HABITUATION; HUMAN; LATENT INHIBITION; LATENT PERIOD; MALE; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; STARTLE REFLEX; SURVIVAL RATE; TASK PERFORMANCE;

ACOUSTIC STIMULATION; ADULT; ANTIPSYCHOTIC AGENTS; AUDITORY PERCEPTION; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; INHIBITION (PSYCHOLOGY); MALE; REACTION TIME; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION;

EID: 0036790015     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01344-6     Document Type: Article

References (90)

1. Acri J.B., Morse D.E., Popke E.J., Grunberg N.E. Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology. 114:1994;369-374.
2. Allan L.M., Williams J.H., Wellman N.A., et al. Effects of tobacco smoking, schizotypy and number of pre-exposures on latent inhibition in healthy subjects. Pers Individual Differences. 19:1995;893-902.
3. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC:1994;American Psychiatric Association.
4. Bakshi V.P., Geyer M.A., Taaid N., Swerdlow N.R. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behav Pharmacol. 6:1995;801-809.
5. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis. 176:1988;598-606.
6. Baruch I., Hemsley D.R., Gray J.A. Latent inhibition and "psychotic proneness" in normal subjects. Pers Individual Differences. 9:1988;777-783.
7. Binder E.B., Kinkead B., Owens M.J., Kilts C.D., Nemeroff C.B. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs Evidence from animal models of sensorimotor gating . J Neurosci. 21:2001;601-608.
8. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
9. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle Normal subjects, patient groups, and pharmacological studies . Psychopharmacology. 156:2001;234-258.
10. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies [see comments]. Arch Gen Psychiatry. 47:1990;181-188.
11. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:1992;206-215.
12. Braff D.L., Swerdlow N.R. Neuroanatomy of schizophrenia [comment]. Schizophr Bull. 23:1997;509-512.
13. Braff D.L., Swerdlow N.R., Geyer M.A. Gating and habituation deficits in the schizophrenia disorders. Clin Neurosci. 3:1995;131-139.
14. Broersen L.M., Feldon J., Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience. 94:1999;39-46.
15. Bruder G., Kayser J., Tenke C., Amador X., Friedman M., Sharif Z., et al. Left temporal lobe dysfunction in schizophrenia Event-related potential and behavioral evidence from phonetic and tonal dichotic listening tasks . Arch Gen Psychiatry. 56:1999;267-276.
16. Cadenhead K.S., Serper Y., Braff D.L. Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiatry. 43:1998;132-138.
17. Cornblatt B.A., Erlenmeyer-Kimling L. Global attentional deviance as a marker of risk for schizophrenia Specificity and predictive validity . J Abnorm Psychol. 94:1985;470-486.
18. Della Casa V. The Influence of Smoking Status and Psychosis Proneness on the Ability to Gate out Irrelevant Information. 1997;169 Swiss Federal Institute of Technology, Zurich.
19. Della Casa V., Hofer I., Feldon J. Latent inhibition in smokers vs. nonsmokers Interaction with number or intensity of preexposures? Pharmacol Biochem Behav. 62:1999;353-359.
20. Della Casa V., Hofer I., Weiner I., Feldon J. The effects of smoking on acoustic prepulse inhibition in healthy men and women. Psychopharmacology. 137:1998;362-368.
21. Duncan E.M., Madonick S., Chakravorty S., Parwani A., Szilagyi S., Efferen T., et al. Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology. 156:2001;266-272.
22. Dunn L.A., Atwater G.E., Kilts C.D. Effects of antipsychotic drugs on latent inhibition Sensitivity and specificity of an animal behavioral model of clinical drug action . Psychopharmacology. 1993:1993;315-323.
23. Elvevag B., Weinberger D.R., Suter J.C., Goldberg T.E. Continuous performance test and schizophrenia A test of stimulus-response compatibility, working memory, response readiness, or none of the above? Am J Psychiatry. 157:2000;772-780.
24. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., Gur R.E. P50 abnormalities in schizophrenia Relationship to clinical and neuropsychological indices of attention . Schizoph Res. 33:1998;157-167.
25. Faraday M.M., O'Donoghue V.A., Grunberg N.E. Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex. Pharmacol Biochem Behav. 62:1999;273-284.
26. Faraday M.M., Rahman M.A., Scheufele P.M., Grunberg N.E. Nicotine administration impairs sensory gating in Long-Evans rats. Pharmacol Biochem Behav. 61:1998;281-289.
27. Feldon J., Weiner I. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biol Psychiatry. 29:1991;635-646.
28. Filion D.L., Dawson M.E., Schell A.M. The psychological significance of human startle eyeblink modification A review . Biol Psychol. 47:1998;1-43.
29. Freedman R., Waldo M., Bickford-Wimer P., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophr Res. 4:1991;233-243.
30. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia A decade in review . Psychopharmacology. 156:2001;117-154.
31. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull. 25:1990;485-498.
32. Ginton A., Urca G., Lubow R.E. The effects of preexposure to a nonattended stimulus on subsequent learning Latent inhibition in adults . Bull Psychonom Soc. 5:1975;5-8.
33. Gray J.A., Joseph M.H., Hemsley D.R., Young A.M., Warburton E.C., Boulenguez P., et al. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition Implications for schizophrenia . Behav Brain Res. 71:1995;19-31.
34. Gray J.A., Mitchell S.N., Joseph M.H., Grigorrigan G.A., Dawe S., Hodges H. Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev Res. 31:1994;3-17.
35. Gray N.S., Hemsley D.R., Gray J.A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol Psychiatry Brain Res. 1:1992;83-89.
36. Gray N.S., Pilowsky L.S., Gray J.A., Kerwin R.W. Latent inhibition in drug naive schizophrenics Relationship to duration of illness and dopamine D2 binding using SPET . Schizophr Res. 17:1995;95-107.
37. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry. 32:1992;939-943.
38. Guy W. ECDEU Assessment Manual for Psychopharmacology. 1976;76-338 U.S. Department of Health, Education, and Welfare: Publication ADM, Washington, DC.
39. Higashima M., Urata K., Kawasaki Y., Maeda Y., Sakai N., Mizukoshi C. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biol Psychiatry. 44:1998;115-120.
40. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle I. Some empirical findings and their implications for how the nervous system processes sensory input . Psychol Rev. 87:1980;175-189.
41. Ito M., Kanno M., Mori Y., Niwa S. Attention deficits assessed by Continuous Performance Test and Span of Apprehension Test in Japanese schizophrenic patients. Schizophr Res. 23:1997;205-211.
42. Kalbfleisch J.D., Prentice R.L. The Statistical Analysis of Failure Time Data. 1980;John Wiley & Sons, New York.
43. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:1987;261-276.
44. Kline L., Decena E., Hitzemann R., McCaughran J. Jr. Acoustic startle, prepulse inhibition, locomotion, and latent inhibition in the neuroleptic-responsive (NR) and neuroleptic-nonresponsive (NNR) lines of mice. Psychopharmacology. 139:1998;322-331.
45. Koch M. The neurobiology of startle. Prog Neurobiol. 59:1999;107-128.
46. Kumari V., Checkley S.A., Gray J.A. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology. 128:1996;54-60.
47. Kumari V., Soni W., Mathew V.M., Sharma T. Prepulse inhibition of the startle response in men with schizophrenia Effects of age of onset of illness, symptoms, and medication . Arch Gen Psychiatry. 57:2000;609-614.
48. Kumari V., Soni W., Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry. 156:1999;1046-1051.
49. Lacroix L., Arimondo P.B., Takasugi M., Helene C., Mergny J.L. Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions. Biochem Biophys Res Commun. 270:2000;363-369.
50. Lacroix L., Broersen L.M., Weiner I., Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 84:1998;431-442.
51. Lacroix L., Spinelli S., Broersen L.M., Feldon J. Blockade of latent inhibition following pharmacological increase or decrease of GABA(A) transmission. Pharmacol Biochem Behav. 66:2000;893-901.
52. Lacroix L., Spinelli S., White W., Feldon J. The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion. Neuroscience. 97:2000;459-468.
53. Lee E.T. Statistical Methods for Survival Data Analysis. 1992;John Wiley & Sons, New York.
54. Lipp O.V., Siddle D.A.T., Arnold S.L. Psychosis proneness in a non-clinical sample 2 A multi-experimental study of "attentional malfunctioning." Pers Individual Differences. 17:1994;405-424.
55. Lubow R.E. Latent inhibition as a measure of learned inattention Some problems and solutions . Behav Brain Res. 88:1997;75-83.
56. Lubow R.E., Gewirtz J.C. Latent inhibition in humans Data, theory, and implications for schizophrenia . Psychol Bull. 117:1995;87-103.
57. Lubow R.E., Weiner I., Schlossberg A., Baruch I. Latent inhibition and schizophrenia. Bull Psychonom Soc. 25:1987;464-467.
58. Martinez Z.A., Oostwegel J., Geyer M.A., Ellison G.D., Swerdlow N.R. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits. Neuropsychopharmacology. 23:2000;517-527.
59. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychopharmacol. 34:1961;103-117.
60. Miller M.B., Chapman L.J., Chapman J.P., Barnett E.M. Schizophrenic deficit in span of apprehension. J Abnorm Psychol. 99:1990;313-316.
61. Moran P.M., Fischer T.R., Hitchcock J.M., Moser P.C. Effects of clozapine on latent inhibition in the rat. Behav Pharmacol. 7:1996;42-48.
62. Moser P.C., Hitchcock J.M., Lister S., Moran P.M. The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Brain Res Rev. 33:2000;275-307.
63. Nüchterlein K.H., Dawson M.E. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull. 10:1984;160-203.
64. Olincy A., Ross R.G., Harris J.G., Young D.A., McAndrews M.A., Cawthra E., et al. The P50 auditory event-evoked potential in adult attention-deficit disorder Comparison with schizophrenia . Biol Psychiatry. 47:2000;969-977.
65. Perry W., Braff D.L. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 151:1994;363-367.
66. Perry W., Geyer M.A., Braff D.L. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry. 56:1999;277-281.
67. Rochford J., Sen A.P., Quirion R. Nicotinic receptor-mediated enhancement of latent inhibition. Soc Neurosci. 21:1995;159.
68. Rochford J., Sen A.P., Quirion R. Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. J Pharmacol Exp Ther. 277:1996;1267-1275.
69. Rund B.R., Oie M., Zeiner P., Sundet K. Span of apprehension in adolescents with schizophrenia or ADHD [letter]. Schizophr Res. 40:1999;257-259.
70. Saccuzzo D.P., Braff D.L., Sprock J., Sudik N. The schizophrenia spectrum A study of the relationship among the Rorschach, MMPI, and visual backward masking . J Clin Psychol. 40:1984;1288-1294.
71. Schauz C., Koch M. Lesions of the nucleus basalis magnocellularis do not impair prepulse inhibition and latent inhibition of fear-potentiated startle in the rat. Brain Res. 815:1999;98-105.
72. Shadach E., Gaisler I., Schiller D., Weiner I. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology. 23:2000;151-161.
73. Strauss M.E., Buchanan R.W., Hale J. Relations between attentional deficits and clinical symptoms in schizophrenic outpatients. Psychiat Res. 47:1993;205-213.
74. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of deficient sensorimotor gating What we know, what we think we know, and what we hope to know soon . Behav Pharmacol. 11:2000;185-204.
75. Swerdlow N.R., Braff D.L., Hartston H., Perry W., Geyer M.A., et al. Latent inhibition in schizophrenia. Schizophr Res. 20:1996;91-103.
76. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 51:1994;139-154.
77. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat Current knowledge and future challenges . Psychopharmacology. 156:2001;194-215.
78. Warburton E.C., Joseph M.H., Feldon J., Weiner I., Gray J.A. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron Implications for a possible antipsychotic action of ondansetron . Psychopharmacology. 114:1994;657-664.
79. Weike A.I., Bauer U., Hamm A.O. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry. 47:2000;61-70.
80. Weiner I., Feldon J. Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology. 91:1987;248-253.
81. Weiner I., Feldon J. The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action Comment on Dunn, Atwater and Kilts (Psychopharmacology 1993;112:315-323.) [letter; comment] . Psychopharmacology. 116:1994;379-381.
82. Weiner I., Feldon J. The switching model of latent inhibition An update of neural substrates . Behav Brain Res. 88:1997;11-25.
83. Weiner I., Lubow R.E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83:1984;194-199.
84. Weiner I., Shadach E., Barkai R., Feldon J. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning Implications for the mechanism of action of neuroleptic drugs . Neuropsychopharmacology. 16:1997;42-50.
85. Weiner I., Shadach E., Tarrasch R., Kidron R., Feldon J. The latent inhibition model of schizophrenia Further validation using the atypical neuroleptic, clozapine . Biol Psychiatry. 40:1996;834-843.
86. Weiss I.C., Domeney A.M., Moreau J.L., Russig H., Feldon J. Dissociation between the effects of pre-weaning and/or post-weaning social isolation on prepulse inhibition and latent inhibition in adult Sprague-Dawley rats. Behav Brain Res. 121:2001;207-218.
87. Wilkinson L.S., Killcross S.S., Humby T., Hall F.S., Geyer M.A., Robbins T.W. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology. 10:1994;61-72.
88. Williams J.H., Wellman N.A., Geaney D.P., Cowen P.J., Feldon J., Rawlins J.N. Reduced latent inhibition in people with schizophrenia An effect of psychosis or of its treatment . Br J Psychiatry. 172:1998;243-249.
89. Williams J.H., Wellmann N.A., Geaney D.P., Cowen P.J., Feldon J., Rawlins J.N. Antipsychotic drug effects in a model of schizophrenic attentional disorder A randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people . Biol Psychiatry. 40:1996;1135-1143.
90. Wishner J., Wahl O. Dichotic listening in schizophrenia. J Consult Clin Psychol. 42:1974;538-546.